Reporting methods of blinding in randomized trials assessing nonpharmacological treatments

PLoS Medicine

Volumn 4, Issue 2, 2007, Pages 0370-0380

  Boutron, Isabelle ^a,b,c   Guittet, Lydia ^a,b,c   Estellat, Candice ^a,b,c   Moher, David ^d,e   Hróbjartsson, Asbjørn ^f   Ravaud, Philippe ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

^d CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAREGIVER; CLINICAL STUDY; HEALTH CARE PERSONNEL; INFORMATION PROCESSING; INTERVENTION STUDY; MEDICAL LITERATURE; METHODOLOGY; PSYCHOTHERAPY; REHABILITATION; SURGICAL TECHNIQUE; DOUBLE BLIND PROCEDURE; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STANDARD;

DOUBLE-BLIND METHOD; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 33847658810     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040061     Document Type: Article

References (57)

1. Gluud LL (2006) Bias in clinical intervention research. Am J Epidemiol 163: 493-501.
2. Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273: 408-412.
3. Schulz KF, Chalmers I, Altman DG (2002) The landscape and lexicon of blinding in randomized trials. Ann Intern Med 136: 254-259.
4. Schulz KF, Grimes DA, Altman DG, Hayes RJ (1996) Blinding and exclusions after allocation in randomised controlled trials: Survey of published parallel group trials in obstetrics and gynaecology. BMJ 312: 742-744.
5. Devereaux PJ, Manns BJ, Ghali WA, Quan H, Lacchetti C, et al. (2001) Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA 285: 2000-2003.
6. Montori V, Bhandari M, Devereaux P, Manns B, Ghali W, et al. (2002) In the dark: The reporting of blinding status in randomized controlled trials. J Clin Epidemiol 55: 787.
7. Hrobjartsson A (2002) What are the main methodological problems in the estimation of placebo effects? J Clin Epidemiol 55: 430-435.
8. Hrobjartsson A, Gotzsche PC (2001) Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 344: 1594-1602.
9. Noseworthy JH, Ebers GC, Vandervoort MK, Farquhar RE, Yetisir E, et al. (1994) The impact of blinding on the results of a randomized, placebocontrolled multiple sclerosis clinical trial. Neurology 44: 16-20.
10. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, et al. (2001) The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 134: 663-694.
11. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, et al. (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352: 609-613.
12. Juni P, Altman DG, Egger M (2001) Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 323: 42-46.
13. Kjaergard LL, Villumsen J, Gluud C (2001) Reported methodologic quality and discrepancies between large and small randomized trials in metaanalyses. Ann Intern Med 135: 982-989.
14. Fergusson D, Glass KC, Waring D, Shapiro S (2004) Turning a blind eye: The success of blinding reported in a random sample of randomised, placebo controlled trials. BMJ 328: 432.
15. Sackett DL (2004) Turning a blind eye: Why we don't test for blindness at the end of our trials. BMJ 328: 1136.
16. Boutron I, Estellat C, Ravaud P (2005) A review of blinding in randomized controlled trials found results inconsistent and questionable. J Clin Epidemiol 58: 1220-1226.
17. Hrobjartsson A, Forfang E, Haahr M, Als-Nielsen B, Stig B (2004) Testing the success of blinding in randomised clinical trials [abstract]. 12th Cochrane Colloquium: Bridging the Gaps;2004 2-6 October; Ottawa, Ontario, Canada. pp 138-139.
18. Boutron I, Tubach F, Giraudeau B, Ravaud P (2004) Blinding was judged more difficult to achieve and maintain in non-pharmacological than pharmacological trials. J Clin Epidemiol 57: 543-550.
19. Boutron I, Tubach F, Giraudeau B, Ravaud P (2003) Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis. JAMA 290: 1062-1070.
20. McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D (2002) Randomised trials in surgery: Problems and possible solutions. BMJ 324: 1448-1451.
21. Lilford R, Braunholtz D, Harris J, Gill T (2004) Trials in surgery. Br J Surg 91: 6-16.
22. Devereaux PJ, Bhandari M, Clarke M, Montori VM, Cook DJ, et al. (2005) Need for expertise based randomised controlled trials. BMJ 330: 88.
23. Devereaux PJ, McKee MD, Yusuf S (2003) Methodologic issues in randomized controlled trials of surgical interventions. Clin Orthop Relat Res: 25-32.
24. Bhandari M, Richards RR, Sprague S, Schemitsch EH (2002) The quality of reporting of randomized trials in the Journal of Bone and Joint Surgery from 1988 through 2000. J Bone Joint Surg Am 84-A: 388-396.
25. Jacquier I, Boutron I, Moher D, Roy C, Ravaud P (2006) The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: A systematic review. Ann Surg 244: 677-683.
26. Ethgen M, Boutron I, Baron G, Giraudeau B, Sibilia J, et al. (2005) Reporting of harm in randomized, controlled trials of nonpharmacologic treatment for rheumatic disease. Ann Intern Med 143: 20-25.
27. Boutron I, Estellat C, Guittet L, Dechartres A, Sackett DL, et al. (2006) Methods of blinding in reports of randomized controlled trials assessing pharmacological treatments. A systematic review. PLoS Med 3: e425. doi:10.1371/journal.pmed.0030425
28. Lee KP, Schotland M, Bacchetti P, Bero LA (2002) Association of journal quality indicators with methodological quality of clinical research articles. JAMA 287: 2805-2808.
29. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, et al. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344: 710-719.
30. Balon J, Aker PD, Crowther ER, Danielson C, Cox PG, et al. (1998) A comparison of active and simulated chiropractic manipulation as adjunctive treatment for childhood asthma. N Engl J Med 339: 1013-1020.
31. Baker KR, Nelson ME, Felson DT, Layne JE, Sarno R, et al. (2001) The efficacy of home based progressive strength training in older adults with knee osteoarthritis: A randomized controlled trial. J Rheumatol 28: 1655-1665.
32. Wolsko PM, Eisenberg DM, Simon LS, Davis RB, Walleczek J, et al. (2004) Double-blind placebo-controlled trial of static magnets for the treatment of osteoarthritis of the knee: Results of a pilot study. Altern Ther Health Med 10: 36-43.
33. Quilty B, Tucker M, Campbell R, Dieppe P (2003) Physiotherapy, including quadriceps exercises and patellar taping, for knee osteoarthritis with predominant patello-femoral joint involvement: Randomized controlled trial. J Rheumatol 30: 1311-1317.
34. Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE (2001) Cognitive behavioral therapy for treatment of chronic primary insomnia: A randomized controlled trial. JAMA 285: 1856-1864.
35. Wang SM, Maranets I, Weinberg ME, Caldwell-Andrews AA, Kain ZN (2004) Parental auricular acupuncture as an adjunct for parental presence during induction of anesthesia. Anesthesiology 100: 1399-1404.
36. Carbajal R, Veerapen S, Couderc S, Jugie M, Ville Y (2003) Analgesic effect of breast feeding in term neonates: Randomised controlled trial. BMJ 326: 13.
37. Boutron I, Moher D, Tugwell P, Giraudeau B, Poiraudeau S, et al. (2005) A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. J Clin Epidemiol 58: 1233-1240.
38. Paterson C, Dieppe P (2005) Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. BMJ 330: 1202-1205.
39. Moseley JB, O'Malley K, Petersen NJ, Menke TJ, Brody BA, et al. (2002) A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 347: 81-88.
40. Spigt MG, Knipschild PG, van Schayck CP, Knottnerus JA (2005) The validity and ethics of giving placebo in a randomized nonpharmacologic trial was evaluated. J Clin Epidemiol 58: 350-356.
41. Zelen M (1992) Randomised consent trials. Lancet 340: 375.
42. Boter H, van Delden JJ, de Haan RJ, Rinkel GJ (2004) Patients' evaluation of informed consent to postponed information: Cohort study. BMJ 329: 86.
43. Bishop FL, Yardley L, Lewith G (2005) Developing a measure of treatment beliefs: The complementary and alternative medicine beliefs inventory. Complement Ther Med 13: 144-149.
44. Devilly GJ, Borkovec TD (2000) Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry 31: 73-86.
45. Torgerson D, Moffett JK (2005) Patient preference and validity of randomized controlled trials. JAMA 294: 41-42.
46. Torgerson DJ, Roland M (1998) What is Zelen's design? BMJ 316: 606.
47. McPherson K, Britton A (1999) The impact of patient treatment preferences on the interpretation of randomised controlled trials. Eur J Cancer 35: 1598-1602.
48. McPherson K, Britton A (2001) Preferences and understanding their effects on health. Qual Health Care 10 Suppl 1: i61-66.
49. McPherson K, Britton AR, Wennberg JE (1997) Are randomized controlled trials controlled? Patient preferences and unblind trials. J R Soc Med 90: 652-656.
50. McPherson K, Chalmers I (1998) Incorporating patient preferences into clinical trials. Information about patients' preference must be obtained first. BMJ 317: 78; discussion 78-79.
51. Halpern S (2003) Evaluating preference effects in partially unblinded, randomized clinical trials. J Clin Epidemiol 56: 109-115.
52. Wood L (2006) The association of allocation and blinding with estimated treatment effect varies according to type of outcome: a combined analysis of meta-epidemiological studies. 14th Cochrane Colloquium:Bridging the Gaps; 2006 23-26 October; Dublin, Ireland.
53. Gerritsen AA, de Vet HC, Scholten RJ, Bertelsmann FW, de Krom MC, et al. (2002) Splinting vs surgery in the treatment of carpal tunnel syndrome: A randomized controlled trial. JAMA 288: 1245-1251.
54. Altman DG, Schulz KF, Moher D (2004) Turning a blind eye: Testing the success of blinding and the CONSORT statement. BMJ 328: 1135-1136.
55. Sackett D, Gent M, Taylor D (1986) Tests for the blindness of randomized trials may not. Clin Res 34: 711A.
56. Senn SJ (2004) Turning a blind eye: Authors have blinkered view of blinding. BMJ 328: 1135-1136.
57. Pildal J, Chan AW, Hrobjartsson A, Forfang E, Altman DG, et al. (2005) Comparison of descriptions of allocation concealment in trial protocols and the published reports: Cohort study. BMJ 330: 1049.